Northwestern Licenses Novel GABA aminotransferase
inhibitors and derivatives of vigabatrin to Catalyst Pharmaceutical Partners. Dr. Richard Silverman, the John Evans Professor of Chemistry at Northwestern University, led the team of scientists that invented the novel compounds. Read More > >
Browse through our Available Technologies › ›